Table 3.
Ureteral Endometriosis N=16 (53%) | Bladder Endometriosis N=15 (50%) | |
---|---|---|
Presence of painful symptoms | ||
Dysmenorrhea | 3 (18.8) | 7 (46.7) |
Deep dyspareunia | 5 (31.6) | 6 (40) |
Non menstrual pain | 5 (31.6) | 7 (46.7) |
Pain evaluation using 10-points analog rating scale* | ||
Dysmenorrhea | 1.6±3.4 | 2.1±2.8 |
Deep dyspareunia | 2.5±3.9 | 2.5±3.5 |
Non menstrual pain | 2.3±3.7 | 2.3±3.1 |
Fertility | ||
Intention to become pregnant after surgery | 2 (12.5) | 7 (46.7) |
Pregnancy | 2 | 4 |
Delivery | 1 | 2 |
MHU (urinary handicap measurement) | ||
- urinary incontinence score | 1.93±2.3 | 1.2±1.7 |
- urinary imperiosity score | 1.5±1.9 | 2.2±1.8 |
- Pollakiuria score | 1.7±1.8 | 1.6±1.7 |
- dysuria score | 0.7±1.3 | 0.8±1.4 |
Endometriosis surgery required due to recurrent complaints | 0 | 0 |
Recovery from endometriosis related pain | 0 | 0 |
Recovery from postoperative complications or additional surgical procedures | **1 (6.3) | **2 (13.3) |
Medical treatment | ||
GnRH analogs | 5 (31.6) | 8 (53.3) |
Progestins | 7 (43.8) | 4 (26.7) |
Contraceptive pills | 1 (6.3) | 3 (20) |
Levonorgestrel intrauterine device | 0 | 0 |
Implanon® | 0 | 0 |
Assisted reproductive techniques | ||
Ovarian stimulation | 2 (12.5) | 3 (20) |
Intrauterine insemination | 0 | 0 |
IVF | 1 (6.3) | 2 (13.3) |